Q1 2026 Holdings
Filed 2026-05-15 | 90 holdings | $969.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Stryker Corporation(SYK) | COM | 863667101 | $50.9M | 154,771 | 5.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $43.3M | 689,822 | 4.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $36.9M | 1,835,506 | 3.8% |
| Insulet Corp(PODD) | COM | 45784P101 | $32.9M | 156,561 | 3.4% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $31.8M | 34,616 | 3.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $29.4M | 431,364 | 3.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $28.9M | 497,035 | 3.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $28.2M | 448,768 | 2.9% |
| CVS Health Corp(CVS) | COM | 126650100 | $27.8M | 387,306 | 2.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $26.1M | 1,207,274 | 2.7% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $25.7M | 403,965 | 2.6% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $24.4M | 269,557 | 2.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $23.9M | 800,037 | 2.5% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $21.6M | 280,575 | 2.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $21.1M | 901,511 | 2.2% |
| Qiagen NV | ORD SHARES | N72482156 | $20.0M | 500,000 | 2.1% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $18.1M | 711,693 | 1.9% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $17.5M | 1,354,800 | 1.8% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $16.3M | 75,000 | 1.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $16.3M | 1,708,099 | 1.7% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $14.8M | 86,702 | 1.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $13.7M | 403,525 | 1.4% |
| Illumina Inc(ILMN) | COM | 452327109 | $13.6M | 110,370 | 1.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $13.4M | 167,155 | 1.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.1M | 99,069 | 1.3% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $12.5M | 259,184 | 1.3% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $11.4M | 411,227 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $11.2M | 232,093 | 1.2% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $11.0M | 12,676 | 1.1% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $11.0M | 336,519 | 1.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $10.9M | 557,936 | 1.1% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $10.7M | 443,058 | 1.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $10.3M | 380,137 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.2M | 322,828 | 1.0% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $10.0M | 1,721,264 | 1.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $9.5M | 50,123 | 1.0% |
| Artivion Inc(AORT) | COM | 228903100 | $9.2M | 252,014 | 1.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $9.0M | 88,078 | 0.9% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $9.0M | 823,763 | 0.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.9M | 26,916 | 0.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $8.9M | 268,160 | 0.9% |
| Immunome Inc(IMNM) | COM | 45257U108 | $8.8M | 403,487 | 0.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $8.6M | 621,458 | 0.9% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $8.4M | 15,000 | 0.9% |
| Waters Corp(WAT) | COM | 941848103 | $7.9M | 26,447 | 0.8% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $7.7M | 551,815 | 0.8% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $7.1M | 786,783 | 0.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $6.6M | 406,702 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $6.5M | 77,686 | 0.7% |
| Cooper COS Inc(COO) | COM | 216648501 | $6.4M | 89,883 | 0.7% |